Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age
Zeruesenay Desta(Indiana University School of Medicine), David A. Flockhart(Indiana University – Purdue University Indianapolis), Anna Maria Storniolo(Indiana University Health), Vered Stearns(Johns Hopkins University), Rachel F. Tyndale(Centre for Addiction and Mental Health), N. Lynn Henry(University of Michigan), Todd C. Skaar(Indiana University School of Medicine), Daniel F. Hayes(University of Michigan–Ann Arbor), Ewa Hoffmann(University of Toronto), Landry K. Kamdem(Harding University Main Campus), L Li(Indiana University – Purdue University Indianapolis), Yvonne Kreutz(Indiana University – Purdue University Indianapolis), Anne Nguyen(Indiana University School of Medicine)
Cited by 108
Related Papers
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k